Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2013 December;38(4) > Minerva Endocrinologica 2013 December;38(4):365-77

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  ENDOCRINE CONTROVERSIES IN PREGNANCY 

Minerva Endocrinologica 2013 December;38(4):365-77

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Hypothyroidism and depression: salient aspects of pathogenesis and management

Duntas L. H. 1, Maillis A. 2, 3

1 Endocrine Unit, Evgenidion Hospital, University of Athens, Athens, Greece; 2 University Research Institute of Mental Health Athens, Greece; 3 Onassio Cardiac Surgery Center, Athens, Greece


PDF


Hypothyroidism has been linked to depression as there is irrefutable evidence that it triggers affective disease and psychic disorders. Depressive patients have a higher frequency of hypothyroidism and patients with hypothyroidism have a higher occurrence of depressive syndrome. Hypothyroidism exhibits considerable alterations in blood flow and glucose metabolism in the brain. Furthermore, patients with major depression may have structural abnormalities of the hippocampus that can affect memory performance. Thyroid peroxidase antibodies have, moreover, been positively associated with trait markers of depression. Depressive symptomatology is variable and is influenced by susceptibility and the degree, though not always, of thyroid failure. In addition, glucose homeostasis and rapid weight loss have been associated to thyroid hormones and increased depressive symptoms. Thyroxine treatment in patients older than 65 years does not improve cognition. In contrast, T3 administration is the therapy of choice in patients with resistance to antidepressive drugs, and especially to SSIR. Genetic variants of thyroid hormone transporters or of deiodinases I and II may predispose to depression and, therefore, a personalized approach should be implemented.

top of page